SARS-CoV-2 is a fatal disease of global public health concern. Measures to reduce its spread critically depend on a timely and accurate diagnosis of virus-infected individuals.
During epidemics and pandemics like COVID-19, the establishment of a sustainable biobanking mechanism for the standardized collection, characterization, and archiving of specimens, and sharing of these specimens to facilitate diagnostic testing, therapeutics development, and knowledge discovery is necessary. As the number of COVID-19 cases and fatalities continue to mount in Uganda, CoV-Bank will continue to support local and international researchers as they respond to the pandemic.
Read this article, where the authors show how a biobank has been a critical resource in the rapid response to coronavirus disease of 2019 (COVID-19) in Uganda.